LEVOLEUCOVORIN for Squamous cell carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where LEVOLEUCOVORIN was used for Squamous cell carcinoma.
Most Reported Side Effects for LEVOLEUCOVORIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 302 | 9.5% | 35 | 163 |
| Nausea | 274 | 8.7% | 36 | 127 |
| Neutropenia | 246 | 7.8% | 19 | 50 |
| Decreased appetite | 223 | 7.0% | 42 | 129 |
| Neuropathy peripheral | 178 | 5.6% | 12 | 41 |
| Neutrophil count decreased | 176 | 5.6% | 39 | 88 |
| Pyrexia | 175 | 5.5% | 23 | 126 |
| Vomiting | 167 | 5.3% | 19 | 100 |
| Febrile neutropenia | 130 | 4.1% | 28 | 65 |
| Off label use | 125 | 4.0% | 21 | 36 |
| Fatigue | 123 | 3.9% | 26 | 72 |
| Anaemia | 120 | 3.8% | 19 | 55 |
| White blood cell count decreased | 119 | 3.8% | 27 | 66 |
| Malaise | 115 | 3.6% | 11 | 59 |
| Interstitial lung disease | 110 | 3.5% | 59 | 55 |
Other Indications for LEVOLEUCOVORIN
Colon cancer (565)
Product used for unknown indication (432)
Rectal cancer (255)
Colorectal cancer metastatic (226)
Pancreatic carcinoma (225)
Adenocarcinoma of colon (184)
Colorectal cancer (107)
Rectal adenocarcinoma (79)
Gastric cancer (73)
Chemotherapy (69)
Other Drugs Used for Squamous cell carcinoma
CARBOPLATIN (608)
CISPLATIN (522)
PACLITAXEL (496)
PEMBROLIZUMAB (470)
FLUOROURACIL (430)
NIVOLUMAB (343)
CETUXIMAB (283)
CEMIPLIMAB-RWLC (234)
DOCETAXEL (198)
GEMCITABINE (109)